Patents by Inventor Yoshimasa Saito
Yoshimasa Saito has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11992766Abstract: At least one memory device of the game system that stores a plurality of instructions, which when executed by the at least one processor, cause the at least one processor to: control a motion of a user object based on first performance information, control a motion of an opponent object based on second performance information, modify performance change information associated with a target area in the virtual space based on a change command from the user or the opponent, change the first performance information in a case where the user object is located in the target area based on the performance change information associated with the target area, and change the second performance information in a case where the opponent object is located in the target area based on the performance change information associated with the target area.Type: GrantFiled: August 30, 2021Date of Patent: May 28, 2024Assignee: KONAMI DIGITAL ENTERTAINMENT CO., LTD.Inventors: Yoshimasa Saito, Tomohiro Nakada, Toru Ono, Yasunori Kobayashi, Kazuma Tsurumoto, Syogo Yamazaki, Yuyaandrew Yamashita
-
Publication number: 20240070937Abstract: According to one embodiment, a medical image processing apparatus includes processing circuitry. The processing circuitry is configured to acquire three-dimensional thermographic image data by imaging a subject irradiated with infrared rays. The processing circuitry is configured to acquire a plurality of items of projection data by imaging the subject with tomosynthesis. The processing circuitry is configured to execute reconstruction based on the plurality of items of projection data and the three-dimensional thermographic image data.Type: ApplicationFiled: August 23, 2023Publication date: February 29, 2024Applicant: Canon Medical Systems CorporationInventors: Yoshimasa KOBAYASHI, Daisuke SATO, Tomio MAEHAMA, Risa HAYASHI, Tamotsu INO, Katsunori KOJIMA, Yoshinori SAITO, Naoto WATANABE
-
Publication number: 20230381659Abstract: A non-transitory storage medium storing a computer program for causing a computer to calculate an action of each object within a field to cause a match between the user and the opponent to proceed, and for providing the game in which the first turn of an offense and the second turn of a defense are switched between the user and the opponent based on a calculation result of the action, wherein the computer program causes the computer to serve as a selection opportunity provision unit that suspends the action of each object in conjunction with switching of the turns and provides an opportunity of selection regarding the match to the user, and a calculation control unit that controls calculation of the match so that the selection by the user is reflected in the calculation of the match within a target period until switching of the turns occurs next.Type: ApplicationFiled: August 11, 2023Publication date: November 30, 2023Applicant: KONAMI DIGITAL ENTERTAIMENT CO., LTD.Inventors: Kazuma TSURUMOTO, Koji ISHII, Syogo YAMAZAKI, Taemin KIM, Yoshimasa SAITO, Yaojen CHANG, Tomohiro NAKADA, Osamu IKEDA, Shota HASEGAWA, Taito ITO, Kuka LEE, Satoshi HIGASHIDA, Yasunori KOBAYASHI, Tomohisa KOIKE, Taro MURAKAMI, Yumi KATO, Chikako IIZUKA, Shuichiro YOSHIMURA
-
Publication number: 20210394067Abstract: At least one memory device of the game system that stores a plurality of instructions, which when executed by the at least one processor, cause the at least one processor to: control a motion of a user object based on first performance information, control a motion of an opponent object based on second performance information, modify performance change information associated with a target area in the virtual space based on a change command from the user or the opponent, change the first performance information in a case where the user object is located in the target area based on the performance change information associated with the target area, and change the second performance information in a case where the opponent object is located in the target area based on the performance change information associated with the target area.Type: ApplicationFiled: August 30, 2021Publication date: December 23, 2021Inventors: Yoshimasa SAITO, Tomohiro NAKADA, Toru ONO, Yasunori KOBAYASHI, Kazuma TSURUMOTO, Syogo YAMAZAKI, Yuyaandrew YAMASHITA
-
Publication number: 20090223823Abstract: A method of separating a protein by gel electrophoresis, which comprises a staining step for bringing a protein-containing sample into contact with a staining liquid containing a staining agent, a surfactant and a buffer solution, and an electrophoresis step for subjecting the protein-containing sample after the staining step to gel electrophoresis. According to the present invention, using a staining liquid containing a surfactant such as SDS and the like, a protein-containing sample can be stained in a short time, and can develop color with high sensitivity. In addition, since an excess staining agent migrates earlier than protein by electrophoresis, a washing operation is not necessary. Furthermore, by staining, after the first dimension electrophoresis, with a staining liquid containing a surfactant such as SDS and the like, the second dimension electrophoresis can be performed immediately.Type: ApplicationFiled: December 6, 2005Publication date: September 10, 2009Applicants: National Institute of Advanced Industrial Science and Technology, Sharp Corporation, Toppan Printing Co., Ltd., Katayanagi InstituteInventors: Ichiji Namatame, Yoshinori Ishii, Yoshimasa Saito, Takayoshi Komatsu, Yasuhiro Ogawa, Takashi Shibata, Hideki Kinoshita, Kenji Yokoyama
-
Patent number: 7037892Abstract: This invention relates to a hematopoietic stem cell proliferating agent comprising IGF-I, a hematopoietic stem cell proliferating agent comprising IGF-I and at least one protein selected from among SCF, M-CSF, and G-CSF, and a method of growing hematopoietic stem cells which comprises culturing hematopoietic stem cells in a medium containing IGF-I and at least one protein selected from the group consisting of SCF and M-CSF. The hematopoietic stem cell proliferating agent of the invention causes hematopoietic stem cells to proliferate in the undifferentiated state whether in vivo or in vitro and can, therefore, be used for amelioration of the cytopenia induced by radiotherapy or chemotherapy using anticancer drugs, prevention of infectious diseases associated with lymphopenia, or in vitro culture for multiplication of hematopoietic stem cells and extrasomatic culture of recombinant stem cells in gene therapy.Type: GrantFiled: July 19, 2002Date of Patent: May 2, 2006Assignee: Astellas Pharma Inc.Inventors: Yoshimasa Saito, Yoshiko Ueda, Kouichi Tamura, Yoko Takata, Hisashi Yamada, Tatsuo Yamashita, Masakazu Kobayashi
-
Patent number: 6825018Abstract: A gene encoding D-sorbitol dehydrogenase (SLDH); a process for producing SLDH by culturing host cells transformed by an expression vector having the above gene; and a process for processing L-sorbose or 2-keto-L-gulonic acid (2KLGA) by using the above culture. 2KLGA is an important intermediate in the production of L-ascorbic acid. Thus, a process for producing L-ascorbic acid from the 2KLGA obtained by the above process is also provided.Type: GrantFiled: December 21, 2001Date of Patent: November 30, 2004Assignee: Fujisawa Pharmaceutical Co. Ltd.Inventors: Takashi Shibata, Chiyo Ichikawa, Mitsutaka Matsuura, Yuji Noguchi, Yoshimasa Saito, Michio Yamashita, Yoko Takata
-
Publication number: 20040235105Abstract: The present invention provide a gene encoding D-sorbitol dehydrogenase (SLDH), a method for producing SLDH by culture of a host cell transformed with a vector expressing this gene and a method for producing L-sorbose or 2-keto-L-gulonic acid (2KLGA) using the culture. 2KLGA is an important intermediate for the production of L-ascorbic acid. Therefore, the present invention also provides a method for producing L-ascorbic acid from the 2KLGA obtained by the above-mentioned method.Type: ApplicationFiled: May 13, 2004Publication date: November 25, 2004Applicant: Fujisawa Pharmaceutical Co. Ltd.Inventors: Takashi Shibata, Chiyo Ichikawa, Mitsutaka Matsuura, Yuji Noguchi, Yoshimasa Saito, Michio Yamashita, Yoko Takata
-
Patent number: 6822714Abstract: An ultraviolet light responsive type liquid crystal alignment films are formed on opposing surfaces of a pair of transparent substrates constituting a liquid crystal cell. Next, the liquid crystal alignment films on the transparent substrates parallel to a reference plane are irradiated by a polarized ultraviolet ray dividedly by the pixel or by the dot so as to regulate an alignment direction of the liquid crystal. Furthermore, the transparent substrate that has been irradiated by the polarized ultraviolet at the previous step is irradiated by the polarized ultraviolet ray dividedly by the pixel or by the dot for developing a pre-tilt angle after rotating the transparent substrate on the reference plane so that the transparent substrate turns to a direction different from its direction at the previous step.Type: GrantFiled: October 16, 2000Date of Patent: November 23, 2004Assignee: Sony CorporationInventor: Yoshimasa Saito
-
Publication number: 20030170811Abstract: The present invention relates to a process for the production of &agr;-human atrial natriuretic polypeptide by recombinant DNA technology.Type: ApplicationFiled: October 24, 2002Publication date: September 11, 2003Applicant: Fujisawa Pharmaceutical Co., Ltd.Inventors: Ikuo Ueda, Mineo Niwa, Yoshimasa Saito, Hisashi Yamada, Yoshinori Ishii
-
Publication number: 20030113912Abstract: This invention relates to a hematopoietic stem cell proliferating agent comprising IGF-I, a hematopoietic stem cell proliferating agent comprising IGF-I and at least one protein selected from among SCF, M-CSF, and G-CSF, and a method of growing hematopoietic stem cells which comprises culturing hematopoietic stem cells in a medium containing IGF-I and at least one protein selected from the group consisting of SCF and M-CSF.Type: ApplicationFiled: September 11, 2002Publication date: June 19, 2003Applicant: Fujisawa Pharmaceutical Co. Ltd.Inventors: Yoshimasa Saito, Yoshiko Ueda, Kouichi Tamura, Yoko Takata, Hisashi Yamada, Tatsuo Yamashita, Masakazu Kobayashi
-
Publication number: 20030068820Abstract: This invention relates to a hematopoietic stem cell proliferating agent comprising IGF-I, a hematopoietic stem cell proliferating agent comprising IGF-I and at least one protein selected from among SCF, M-CSF, and G-CSF, and a method of growing hematopoietic stem cells which comprises culturing hematopoietic stem cells in a medium containing IGF-I and at least one protein selected from the group consisting of SCF and M-CSF.Type: ApplicationFiled: July 19, 2002Publication date: April 10, 2003Applicant: Fujisawa Pharmaceutical Co., Ltd.Inventors: Yoshimasa Saito, Yoshiko Ueda, Kouichi Tamura, Yoko Takata, Hisashi Yamada, Tatsuo Yamashita, Masakazu Kobayashi
-
Patent number: 6495365Abstract: This invention relates to a hematopoietic stem cell proliferating agent comprising IGF-I, a hematopoietic stem cell proliferating agent comprising IGF-I and at least one protein selected from among SCF, M-CSF, and G-CSF, and a method of growing hematopoietic stem cells which comprises culturing hematopoietic stem cells in a medium containing IGF-I and at least one protein selected from the group consisting of SCF and M-CSF. The hematopoietic stem cell proliferating agent of the invention causes hematopoietic stem cells to proliferate in the undifferentiated state whether in vivo or in vitro and can, therefore, be used for amelioration of the cytopenia induced by radiotherapy or chemotherapy using anticancer drugs, prevention of infectious diseases associated with lymphopenia, or in vitro culture for multiplication of hematopoietic stem cells and extrasomatic culture of recombinant stem cells in gene therapy.Type: GrantFiled: May 13, 1999Date of Patent: December 17, 2002Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Yoshimasa Saito, Yoshiko Ueda, Kouichi Tamura, Yoko Takata, Hisashi Yamada, Tatsuo Yamashita, Masakazu Kobayashi
-
Patent number: 6470263Abstract: In a navigation system for vehicles, a type of road a vehicle travels is determined based on a present position of a vehicle and road data, and a change in the type of road is determined. The road type is determined based on the type of link the vehicle travels referring to a table storing a relation between a link type and a road type. A travel distance is accumulated until the travel distance exceeds a predetermined determination reference, when the road type remains unchanged. An instant vehicle speed is calculated each time the vehicle travels the determination reference. An average vehicle speed is calculated by using the instant vehicle speed calculated for each road type. The average vehicle speed is used to notify an estimated time of arrival at a destination or a passing point.Type: GrantFiled: May 17, 2001Date of Patent: October 22, 2002Assignee: Denso CorporationInventors: Tomohiro Ito, Shinji Hiraiwa, Yoshimasa Saito
-
Publication number: 20020081676Abstract: In a method for producing an oxide which comprises cultivating a strain of microorganism of the genus Gluconobacter, the genus Acetobacter, the genus_Pseudogluconobacter, the genus Pseudomonas, the genus_Corynebacterium, or the genus Erwinia to oxidize a substrate in a culture medium, an assimilable carbon source other than the substrate is admixed in the medium.Type: ApplicationFiled: October 15, 1999Publication date: June 27, 2002Inventors: MASARU YOSHIDA, SHINSUKE SOEDA, KATUYOSHI HAYASHI, HIDEMITSU NANIN, YUJI NOGUCHI, YOSHIMASA SAITO
-
Patent number: D877105Type: GrantFiled: June 21, 2018Date of Patent: March 3, 2020Assignee: SAKAI DISPLAY PRODUCTS CORPORATIONInventors: Yoshimasa Saito, Hideyuki Shirai
-
Patent number: D879059Type: GrantFiled: June 21, 2018Date of Patent: March 24, 2020Assignee: SAKAI DISPLAY PRODUCTS CORPORATIONInventors: Yoshimasa Saito, Hideyuki Shirai
-
Patent number: D881882Type: GrantFiled: July 5, 2018Date of Patent: April 21, 2020Assignee: SAKAI DISPLAY PRODUCTS CORPORATIONInventors: Hideyuki Shirai, Yoshimasa Saito
-
Patent number: D888705Type: GrantFiled: December 20, 2018Date of Patent: June 30, 2020Assignee: SAKAI DISPLAY PRODUCTS CORPORATIONInventors: Yoshimasa Saito, Hideyuki Shirai
-
Patent number: D897977Type: GrantFiled: December 20, 2018Date of Patent: October 6, 2020Assignee: SAKAI DISPLAY PRODUCTS CORPORATIONInventors: Yoshimasa Saito, Hideyuki Shirai